Presenter
Oliver M Barry, MD, FSCAI, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY
Oliver M Barry, MD, FSCAI, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY
Learning Objectives:
- Describe the rationale for use of systemic agents such as rapamycin for PVS
- Discuss the impact of the use of systemic agents on the outcome of PVS